The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force.


Journal

The Gulf journal of oncology
ISSN: 2078-2101
Titre abrégé: Gulf J Oncolog
Pays: Kuwait
ID NLM: 101500911

Informations de publication

Date de publication:
Jan 2020
Historique:
accepted: 02 12 2019
entrez: 29 4 2020
pubmed: 29 4 2020
medline: 24 10 2020
Statut: ppublish

Résumé

With cancer being the third leading cause of mortality in the United Arab Emirates (UAE), there has been significant investment from the government and private health care providers to enhance the quality of cancer care in the UAE. The UAE is a developing country with solid economic resources that can be utilized to improve cancer care across the country. There is limited data regarding the incidence, survival, and potential risk factors for cancer in the UAE. The UAE Oncology Task Force was established in 2019 by cancer care providers from across the UAE under the auspices of Emirates Oncology Society. In this paper we summarize the history of cancer care in the UAE, report the national cancer incidence, and outline current challenges and opportunities to enhance and standardize cancer care. We provide recommendations for policymakers and the UAE Oncology community for the delivery of high-quality cancer care. These recommendations are aligned with the UAE government's vision to reduce cancer mortality and provide high quality healthcare for its citizens.

Identifiants

pubmed: 32342923

Types de publication

Historical Article Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

71-87

Auteurs

Humaid Al-Shamsi (H)

Emirates Oncology Society, Dubai, United Arab Emirates.
Department of Clinical Science, College of Medicine, University of Sharjah.

Humaa Darr (H)

Emirates Oncology Society, Dubai, United Arab Emirates.
Alzahra Hospital, Dubai, United Arab Emirates.

Ibrahim Abu-Gheida (I)

Emirates Oncology Society, Dubai, United Arab Emirates.
Burjeel Medical City, Abu Dhabi, United Arab Emirates.

Jawaher Ansari (J)

Emirates Oncology Society, Dubai, United Arab Emirates.
Department of Oncology, Tawam Hospital, Al-Ain, United Arab Emirates.

Martine C McManus (MC)

Emirates Oncology Society, Dubai, United Arab Emirates.
Burjeel Medical City, Abu Dhabi, United Arab Emirates.

Hassan Jaafar (H)

Emirates Oncology Society, Dubai, United Arab Emirates.
Oncology Department, Sheikh Khalifa Speciality Hospital, Ras Al-Khaimah, United Arab Emirates.

Syed Hammad Tirmazy (SH)

Emirates Oncology Society, Dubai, United Arab Emirates.
Oncology Department, Dubai Hospital, Dubai, United Arab Emirates.

Maroun Elkhoury (M)

Emirates Oncology Society, Dubai, United Arab Emirates.
American Hospital, Dubai , United Arab Emirates.

Fathi Azribi (F)

Emirates Oncology Society, Dubai, United Arab Emirates.
Department of Oncology, Tawam Hospital, Al-Ain, United Arab Emirates.

Danijela Jelovac (D)

Department of Oncology, Tawam Hospital, Al-Ain, United Arab Emirates.
Breast Cancer Program, The Joh Hopkins Sydney Kimmel Comprehensive Cancer Center Baltimore, MD, USA.

Tarik A Doufan (TA)

Emirates Oncology Society, Dubai, United Arab Emirates.
American Hospital, Dubai , United Arab Emirates.

Abdel Rahman Labban (AR)

Emirates Oncology Society, Dubai, United Arab Emirates.
Advanced Care Oncology Center, Dubai , United Arab Emirates.

Ahmad Ali Basha (AA)

Emirates Oncology Society, Dubai, United Arab Emirates.
Saudi German Hospital Dubai , Dubai, United Arab Emirates.

Ahmed Samir (A)

Emirates Oncology Society, Dubai, United Arab Emirates.
Alzahra Hospital, Dubai, United Arab Emirates.

Aladdin Maarraoui (A)

Emirates Oncology Society, Dubai, United Arab Emirates.
Gulf International Cancer Center, Abu Dhabi, United Arab Emirates.

Ali Al Dameh (A)

Emirates Oncology Society, Dubai, United Arab Emirates.
American Hospital, Dubai , United Arab Emirates.

Aydah Al-Awadhi (A)

Emirates Oncology Society, Dubai, United Arab Emirates.
Department of Oncology, Tawam Hospital, Al-Ain, United Arab Emirates.

Basel Al Haj Ali (B)

Emirates Oncology Society, Dubai, United Arab Emirates.
Oncology Department, Sheikh Khalifa Speciality Hospital, Ras Al-Khaimah, United Arab Emirates.

Batool Aboud (B)

Emirates Oncology Society, Dubai, United Arab Emirates.
Oncology Department, Sheikh Khalifa Speciality Hospital, Ras Al-Khaimah, United Arab Emirates.

Dalia Elshorbagy (D)

Emirates Oncology Society, Dubai, United Arab Emirates.
Oncology Department, Dubai Hospital, Dubai, United Arab Emirates.

Diaa Trad (D)

Emirates Oncology Society, Dubai, United Arab Emirates.
Department of Oncology, Tawam Hospital, Al-Ain, United Arab Emirates.

Dima Abdul Jabbar (D)

Emirates Oncology Society, Dubai, United Arab Emirates.
American Hospital, Dubai , United Arab Emirates.

Dina Hamza (D)

Emirates Oncology Society, Dubai, United Arab Emirates.
Oncology Department, Dubai Hospital, Dubai, United Arab Emirates.

Ed Ashtar (E)

Emirates Oncology Society, Dubai, United Arab Emirates.
Alzahra Hospital, Dubai, United Arab Emirates.

Emad Dawoud (E)

Emirates Oncology Society, Dubai, United Arab Emirates.
Department of Oncology, Tawam Hospital, Al-Ain, United Arab Emirates.

Essa M Aleassa (EM)

Department of Surgery, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates.
Section of Hepatopancreatobiliary Surgery, Department of Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic Foundation, Cleveland, OH, United States of America.

Faraz Khan (F)

Emirates Oncology Society, Dubai, United Arab Emirates.
American Hospital, Dubai , United Arab Emirates.

Faryal Iqbal (F)

Burjeel Medical City, Abu Dhabi, United Arab Emirates.

Hala Abdellatif (H)

Mediclinic Al Noor Hospital, Abu Dhabi, United Arab Emirates.

Mehdi Afrit (M)

Mediclinic Al Noor Hospital, Abu Dhabi, United Arab Emirates.

Mohamad H Masri (MH)

Cleveland Clinic Abu Dhabi , Abu Dhabi , United Arab Emirates.

Mohamed Abuhaleeqa (M)

Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.

Mohamed Alfalasi (M)

Department of Surgery, Tawam Hospital, Al-Ain, United Arab Emirates.

Mohamed Omara (M)

Emirates Oncology Society, Dubai, United Arab Emirates.
Oncology Department, Dubai Hospital, Dubai, United Arab Emirates.

Mohanad Diab (M)

NMC Specialty Hospital, Abu Dhabi , United Arab Emirates.

Muhammad Farooq Latif (MF)

Emirates Oncology Society, Dubai, United Arab Emirates.
Oncology Department, Dubai Hospital, Dubai, United Arab Emirates.

Muharram Oner (M)

Emirates Oncology Society, Dubai, United Arab Emirates.
Alzahra Hospital, Dubai, United Arab Emirates.

Norbert Dreier (N)

Burjeel Medical City, Abu Dhabi, United Arab Emirates.

Omar Almarzouqi (O)

Department of Surgery, Rashid Hospital, Dubai, United Arab Emirates.

R A Singarachari (RA)

Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.

Riyad Bendardaf (R)

Department of Clinical Science, College of Medicine, University of Sharjah.

Sadir Alrawi (S)

Emirates Oncology Society, Dubai, United Arab Emirates.
Alzahra Hospital, Dubai, United Arab Emirates.

Salman Sray Aldeen (SS)

Emirates Oncology Society, Dubai, United Arab Emirates.
Oncology Department, Sheikh Khalifa Speciality Hospital, Ras Al-Khaimah, United Arab Emirates.

Shabeeha Rana (S)

Emirates Oncology Society, Dubai, United Arab Emirates.
Alzahra Hospital, Dubai, United Arab Emirates.

Soha Talima (S)

Zulekha Hospital Dubai, Dubai, United Arab Emirates.

Tamer Abdelgawad (T)

Emirates Oncology Society, Dubai, United Arab Emirates.
Advanced Care Oncology Center, Dubai , United Arab Emirates.

Abhinav Ahluwalia (A)

Emirates Oncology Society, Dubai, United Arab Emirates.
Advanced Care Oncology Center, Dubai , United Arab Emirates.

Thamir Alkasab (T)

Emirates Oncology Society, Dubai, United Arab Emirates.
Alzahra Hospital, Dubai, United Arab Emirates.

Tamer Madi (T)

Emirates Oncology Society, Dubai, United Arab Emirates.
Alzahra Hospital, Dubai, United Arab Emirates.

Tarek Alkhouri (T)

Emirates Oncology Society, Dubai, United Arab Emirates.
Zulekha Hospital Dubai, Dubai, United Arab Emirates.

Urfan Ul Haq (U)

Burjeel Hospital, Abu Dhabi, United Arab Emirates.

Yazan Z Alabed (YZ)

Gulf International Cancer Center, Abu Dhabi, United Arab Emirates.

Mohamad Azzam (M)

Mediclinic Airport Road Cancer Center, Abu Dhabi, United Arab Emirates.

Zulfaqqar Ali (Z)

Alzahra Hospital NMC , Shajah , United Arab Emirates.

Maher A Abbas (MA)

Dubai Colorectal Clinic, Dubai United Arab Emirates.

Aly Abdel Razek (AA)

Emirates Oncology Society, Dubai, United Arab Emirates.
Gulf International Cancer Center, Abu Dhabi, United Arab Emirates.

Falah Al-Khatib (F)

Mediclinic City Hospital, Dubai United Arab Emirates.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH